BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31279691)

  • 1. Evolving Trends for Selected Treatments of T1a Renal Cell Carcinoma.
    Doolittle J; Piotrowski J; Zuk K; Jacobsohn K; Langenstroer P; See W; Johnson S
    Urology; 2019 Oct; 132():136-142. PubMed ID: 31279691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolving practice patterns for the management of small renal masses in the USA.
    Yang G; Villalta JD; Meng MV; Whitson JM
    BJU Int; 2012 Oct; 110(8):1156-61. PubMed ID: 22372984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National treatment trends among older patients with T1-localized renal cell carcinoma.
    Kim SP; Gross CP; Meropol N; Kutikov A; Smaldone MC; Shah ND; Yu JB; Psutka S; Kiechle J; Abouassaly R
    Urol Oncol; 2017 Mar; 35(3):113.e15-113.e21. PubMed ID: 27839926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
    Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Renal Masses in an Octogenarian Cohort: Is There a Right Approach?
    Tang DH; Nawlo J; Chipollini J; Gilbert SM; Poch M; Pow-Sang JM; Sexton WJ; Spiess PE
    Clin Genitourin Cancer; 2017 Dec; 15(6):696-703. PubMed ID: 28566202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
    Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
    Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients.
    Parker WP; Cheville JC; Frank I; Zaid HB; Lohse CM; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2017 Apr; 71(4):665-673. PubMed ID: 27287995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the surgical management of localized renal masses: thermal ablation, partial and radical nephrectomy in the USA, 1998-2008.
    Woldrich JM; Palazzi K; Stroup SP; Sur RL; Parsons JK; Chang D; Derweesh IH
    BJU Int; 2013 Jun; 111(8):1261-8. PubMed ID: 23470140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.
    Petros FG; Keskin SK; Yu KJ; Li R; Metcalfe MJ; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    Urology; 2018 Jun; 116():114-119. PubMed ID: 29578041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiographic characteristics governing the selection of therapy of small renal masses.
    Jackson M; Cusano A; Haddock P; Staff I; Abarzua-Cabezas F; Kesler S; Meraney A; Shichman S
    Can J Urol; 2014 Dec; 21(6):7529-35. PubMed ID: 25483759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in the treatment of clinical T1 renal cell carcinoma for octogenarians: Analysis of the National Cancer Database.
    Miller C; Raza SJ; Davaro F; May A; Siddiqui S; Hamilton ZA
    J Geriatr Oncol; 2019 Mar; 10(2):285-291. PubMed ID: 30528544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL Score.
    Kopp RP; Liss MA; Mehrazin R; Wang S; Lee HJ; Jabaji R; Mirheydar HS; Gillis K; Patel N; Palazzi KL; Wan JY; Patterson AL; Derweesh IH
    Urology; 2015 Aug; 86(2):312-9. PubMed ID: 26189330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
    BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of progression to end-stage renal disease requiring dialysis after partial or radical nephrectomy for renal cell carcinoma in patients with severe chronic kidney disease.
    Takagi T; Kondo T; Omae K; Iizuka J; Kobayashi H; Yoshida K; Hashimoto Y; Tanabe K
    Int Urol Nephrol; 2016 Sep; 48(9):1421-7. PubMed ID: 27193433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.